Internal Medicine, Endocrinology, Diabetes, & Metabolism · Louisville, KY
NPI
1811962350
Since 2006
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
9720 Park Plaza Ave Unit 104
Louisville, KY, 40241
Phone (502) 895-8218
Groups this clinician bills Medicare through
Medicare paid, 2024
$91K
1,498 services
Medicare patients, 2024
616
Average age 70
Drug cost, 2024
$6.6M
11,262 prescriptions
Company payments, 2025
$105K
From 32 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Hisham A Alrefai was code 99213 (office e&m - established), 1,042 times for 532 patients. In total Hisham A Alrefai billed 1,498 services in 6 codes, and Medicare paid $91K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-02-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 1,042 | 532 | $55.96 | $58K |
| 99214 Office E&M - Established | Office | 270 | 183 | $78.24 | $21K |
| 95251 Test - Miscellaneous | Office | 73 | 45 | $21.86 | $1,596 |
| 99203 Office E&M - New | Office | 60 | 60 | $72.01 | $4,321 |
| 99204 Office E&M - New | Office | 52 | 52 | $102.19 | $5,314 |
By year: 2022 $111K for 1,707 services; 2023 $105K for 1,493 services; 2024 $91K for 1,498 services.
Medicare prescription drug claims, 2024
In 2024, the drug Hisham A Alrefai prescribed most often to Medicare patients was Ozempic (Semaglutide), with 818 prescriptions and refills. In total Hisham A Alrefai wrote 11,262 Medicare prescriptions that cost $6.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Ozempic Semaglutide | 818 | 1,204 | 184 | $1.1M |
| Synthroid Levothyroxine Sodium | 626 | 1,147 | 144 | $52K |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 504 | 797 | 163 | $113K |
| Levothyroxine Sodium Generic | 460 | 956 | 126 | $4,816 |
| Omnipod 5 Dexg7g6 Pods (Gen 5) Insulin Pump Cart,auto,bt,g6/7 | 408 | 589 | 86 | $401K |
| Metformin Hcl Generic | 370 | 876 | 109 | $3,111 |
| Gabapentin Generic | 296 | 348 | 62 | $2,825 |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 295 | 504 | 103 | $33K |
| Omnipod Dash Pods (Gen 4) Insulin Pump Cart,cont Inf,bt | 260 | 422 | 62 | $313K |
| Humalog Insulin Lispro | 242 | 433 | 90 | $82K |
| Farxiga Dapagliflozin Propanediol | 241 | 385 | 58 | $212K |
| Humulin R U-500 Insulin Regular, Human | 228 | 256 | 47 | $351K |
| Tresiba Flextouch U-200 Insulin Degludec | 223 | 378 | 62 | $381K |
| Cequr Simplicity Bolus Insulin Pump, 200 Unit | 218 | 246 | 83 | $115K |
| Atorvastatin Calcium Generic | 202 | 527 | 63 | $1,330 |
Brand drugs: 6,172 claims; generic drugs: 3,313 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Hisham A Alrefai $105K ($105K in general payments such as food, travel and fees) from 32 companies. The largest payer was Novo Nordisk Inc with $40K.
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc NVO | 52 | $40K |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 47 | $30K |
| Corcept Therapeutics CORT | 54 | $30K |
| CeQur Corporation | 3 | $1,651 |
| Alexion Pharmaceuticals, Inc. AZN | 22 | $519 |
| Insulet Corporation PODD | 28 | $413 |
| Chiesi USA, Inc. | 4 | $344 |
| Medtronic, Inc. MDT | 12 | $310 |
| Recordati_rare_diseases_inc. | 17 | $246 |
| Amgen Inc. AMGN | 15 | $240 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.